232 - Particularities of smoking cessation treatment in a female population with multimorbidities (ID 1293)
Abstract
Background and Aims
Objectives: To describe the profile of female smokers among users assisted in an outpatient clinic for smoking cessation treatment.
Methods
Methods: Longitudinal study, referring to 59 consecutive treatment groups, conducted by multidisciplinary team, sensitization sessions, cognitive behavioural approach (CBA), followed by periodic evaluations up to 12 months.
Results
Results: A sample of 383 smokers, 64.1% of female, 55.7±8.6 years and 67% of low schooling. Compared with men, women were characterized by a significant association with physical inactivity (p <0.053), abdominal obesity (p <0.001), higher serum cholesterol levels (p <0.005), depression (p <0.001) and peripheral vascular disease (p <0.014). Interestingly, stroke was significantly lower in women (p <0.008). As for the smoking history, it was observed that women stopped smoking less at the 4th week of treatment (p <0.012) but used medications (bupropion and nicotine replacement therapy) at higher frequencies (p <0.001). It was observed that women tended to have higher levels of expired carbon monoxide at the first meeting (p <0.07) and consumed less alcohol abusively (p <0.001).
Conclusions
Conclusion: There was a higher prevalence of women smokers with multimorbidities than men. Signalling for peripheral vascular disease among atherosclerotic diseases alerts us to the greater screening and diagnosis of this comorbidity. The incentive to physical activity for this population could reduce other specificities found. The increased use of combined drugs observed did not guarantee a higher cessation rate. To extend the range of smoking cessation, the approach needs to be tailored to female specificities.
